Skip to main content
. 2015 Feb 25;2015(2):CD007897. doi: 10.1002/14651858.CD007897.pub3

Comparison 5. Mould remediation versus no exposure in schools ‐ effects in children.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Asthma‐related outcomes CBA 3   Odds Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.1 Coughing before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Coughing after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Dyspnoea before intervention 2   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Dyspnoea after intervention 2   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Wheezing before intervention 2   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 Wheezing after intervention 2   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Respiratory infections CBA 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 All respiratory infections at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 All respiratory infections at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Common cold at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Common cold at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.5 Tonsillitis at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.6 Tonsillitis at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.7 Otitis at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.8 Otitis at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.9 Sinusitis at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.10 Sinusitis at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.11 Bronchitis or pneumonia at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.12 Bronchitis or pneumonia at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.13 Use antibiotics at baseline 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.14 Use antibiotics at follow‐up 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Respiratory symptoms CBA 3   Odds Ratio (M‐H, Fixed, 95% CI) Totals not selected
3.1 Eye irritation before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Eye irritation after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Stuffy nose before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Stuffy nose after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 Runny nose before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.6 Runny nose after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.7 Dry throat before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.8 Dry throat after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.9 Hoarseness before intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.10 Hoarseness after intervention 3   Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]